Science Explorer Back to mapMap
Discussion

Bionex Pharmaceuticals (United States)

Research works
1
fractional, all time
Citations
14
18.7 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
33%
world 40%
Bionex Pharmaceuticals (United States)

Not ranked overall: Bionex Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Bionex Pharmaceuticals (United States) work in?

In all years, 88% of research at Bionex Pharmaceuticals (United States) is in Life Sciences, 13% in Health Sciences. Its largest fields are Pharmacology, Toxicology and Pharmaceutics (63%), Biochemistry, Genetics and Molecular Biology (13%), Neuroscience (13%).

Life Sciences88%Health Sciences13%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Pharmacology, Toxicology and Pharmaceutics062.5%
    2. Biochemistry, Genetics and Molecular Biology012.5%
    3. Neuroscience012.5%
    1. Medicine012.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Bionex Pharmaceuticals (United States)?

The most cited paper from Bionex Pharmaceuticals (United States) is "Effect of surfactants and pH on naltrexone (NTX) permeation across buccal mucosa" (Vishwas Rai, Hock Seng Tan, Bozena B. Michniak‐Kohn, 2011), with 25 citations. Next come "Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposure" (6) and "Technical Note: Comparison of USP Apparatus 5 and 7 for In Vitro Drug Release from Nicotine Transdermal Systems" (2).

Most cited papers
#PaperReleasedCitations
1 Effect of surfactants and pH on naltrexone (NTX) permeation across buccal mucosa Vishwas Rai, Hock Seng Tan, Bozena B. Michniak‐Kohn · International Journal of Pharmaceutics Open access 4 Apr 2011 25
2 Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposure Jessica M. Yingst, Courtney Lester, Craig Livelsberger et al. · Brain Research Bulletin Open access 25 Jul 2022 6
3 Technical Note: Comparison of USP Apparatus 5 and 7 for In Vitro Drug Release from Nicotine Transdermal Systems Ming Li, Hock Seng Tan · Dissolution Technologies Open access 2019 2
All 3 most cited papers, with filters and sorting

Which research topics does Bionex Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Vagus Nerve Stimulation Research, Nicotinic Acetylcholine Receptors Study and Smoking Behavior and Cessation.

  1. 1 Vagus Nerve Stimulation Research Neurology 0 works
  2. 2 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
  3. 3 Smoking Behavior and Cessation Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.3%not open66.7%

World: 40% of research is openly available.

Other research institutions in New Brunswick

All research institutions in New Brunswick

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Bionex Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.